Sign In
Buy LH
$258.92
+1.22 (+0.473%)
At Close: Jun 03, 2026
LabCorp (LH) Q2 Earnings Top Estimates, Raises '22 EPS View
05:15pm, Thursday, 28'th Jul 2022 Zacks Investment Research
LabCorp (LH) posts better-than-expected earnings in the second quarter and demonstrates continued strength in the organic Base Business.
Laboratory Corporation of America Holdings (LH) CEO Adam Schechter on Q2 2022 Results - Earnings Call Transcript
03:24pm, Thursday, 28'th Jul 2022
Laboratory Corporation of America Holdings (NYSE:LH ) Q2 2022 Earnings Conference Call July 28, 2022 9:00 AM ET Company Participants Chas Cook - VP, IR Adam Schechter - President, CEO & Chairman Glenn
LabCorp (LH) Q2 Earnings Beat Estimates
12:35pm, Thursday, 28'th Jul 2022 Zacks Investment Research
LabCorp (LH) delivered earnings and revenue surprises of 6.21% and 3.19%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
LabCorp (LH) Q2 Earnings Beat Estimates
10:11am, Thursday, 28'th Jul 2022
LabCorp (LH) delivered earnings and revenue surprises of 6.21% and 3.19%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Labcorp to spin off its clinical-development business
07:45am, Thursday, 28'th Jul 2022
Shares of Labcorp LH, +1.03% gained 4.2% in premarket trading on Thursday after beating earnings expectations for the second quarter and announcing plans to spin off its clinical-development business,
Medical Device Stocks to Watch for Earnings on Jul 28
04:05pm, Wednesday, 27'th Jul 2022 Zacks Investment Research
Medical Device players are likely to have benefited from the reopening of economies and several efforts to combat staffing challenges. Let's see how LH, TMO and BIO will likely fare this time.
Is a Beat Likely for AmerisourceBergen (ABC) in Q3 Earnings?
03:00pm, Wednesday, 27'th Jul 2022 Zacks Investment Research
AmerisourceBergen's (ABC) fiscal third-quarter results are likely to reflect solid performance at the U.S. Healthcare Solutions segment.
Can LabCorp (LH) Keep the Earnings Surprise Streak Alive?
04:10pm, Thursday, 21'st Jul 2022 Zacks Investment Research
LabCorp (LH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
LabCorp (LH) to Offer New Test Report for Venom Allergy Testing
04:41pm, Wednesday, 20'th Jul 2022 Zacks Investment Research
LabCorp's (LH) newly-launched interpretative venom allergy report will inform enhanced treatment decisions in case of venomous insect stings.
LabCorp (LH) to Report Q2 Earnings: What's in the Cards?
01:16pm, Wednesday, 20'th Jul 2022 Zacks Investment Research
LabCorp's (LH) Diagnostics base business organic volume is anticipated to have continued its rally in Q2, led by consistent growth in esoteric and routine procedures.
Labcorp to Announce Second Quarter Financial Results on July 28, 2022
05:43pm, Thursday, 14'th Jul 2022
BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading global life sciences company, will release its financial results for the second quarter of 2022 before the market opens on Thursday, Ju
LabCorp (LH) Debuts NfL Test for Neuronal Damage Diagnosis
03:42pm, Thursday, 14'th Jul 2022 Zacks Investment Research
LabCorp's (LH) widely accessible NfL blood test presents direct evidence of neuronal injury resulting from brain injury or diseases like Alzheimer's, among others.
LabCorp (LH) Debuts NfL Test for Neuronal Damage Diagnosis
01:10pm, Thursday, 14'th Jul 2022
LabCorp's (LH) widely accessible NfL blood test presents direct evidence of neuronal injury resulting from brain injury or diseases like Alzheimer's, among others.
LabCorp's (LH) Base Testing Volume Grows, Costs Rise
03:31pm, Friday, 08'th Jul 2022 Zacks Investment Research
LabCorp's (LH) slew of product launches and collaborations to pursue short- and long-term high-growth opportunities instill optimism.
LabCorp's (LH) Base Testing Volume Grows, Costs Rise
01:13pm, Friday, 08'th Jul 2022
LabCorp's (LH) slew of product launches and collaborations to pursue short- and long-term high-growth opportunities instill optimism.
